Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Immunoblastic Lymphadenopathy 1

Interventions

Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Cyclosporine 5fludarabine phosphate 4Melphalan 4Mycophenolic Acid 3Methotrexate 3Etoposide 3Cytarabine 3Cyclophosphamide 3Carmustine 3Busulfan 3Antilymphocyte Serum 3Vincristine 2Thiotepa 2Prednisone 2Magnetic Resonance Spectroscopy 2Leucovorin 2Doxorubicin 2Carboplatin 2thymoglobulin 1plerixafor 1etoposide phosphate 1denileukin diftitox 1amuvatinib 1Vindesine 1Vinblastine 1Triamcinolone Acetonide 1Therapeutics 1Salvia hispanica seed extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large-Cell, Anaplastic × denileukin diftitox × Clear all
NCT00513188 2016-12-15

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

University of Miami

Phase NA Withdrawn
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡